T42.2X2D Poisoning by succinimides and oxazolidinediones, intentional self-harm, subsequent encounter

Name of the Condition

Poisoning by succinimides and oxazolidinediones, intentional self-harm, subsequent encounter
ICD-10 Code: T42.2X2D

Summary

This code applies to intentional self-harm poisoning by succinimides or oxazolidinediones during a subsequent encounter. It is used when the patient has a history of intentional self-harm with these medications and is receiving ongoing care. The classification reflects the nature of the exposure (intentional self-harm) and the encounter type (subsequent).

Causes

Intentional self-harm poisoning may result from deliberate overdose or misuse of succinimides or oxazolidinediones. Contributing factors can include underlying psychiatric conditions, emotional distress, or access to these medications. The subsequent encounter indicates ongoing management of the self-harm event.

Risk Factors

• History of intentional self-harm or suicidal behavior.
• Underlying psychiatric disorders (e.g., depression, anxiety).
• Access to succinimides or oxazolidinediones.
• Lack of social support or mental health resources.
• Prior episodes of self-harm or overdose.

Symptoms

• Neurological: Drowsiness, confusion, ataxia, nystagmus, or seizures.
• Gastrointestinal: Nausea, vomiting, or abdominal pain.
• Cardiovascular: Hypotension or arrhythmias.
• Respiratory: Respiratory depression or failure.
• Behavioral: Altered mental status or agitation.

Diagnosis

Diagnosis involves clinical evaluation, medication history, and laboratory testing to confirm exposure. Documentation should include details of the self-harm event, clinical findings, and any prior treatments. The subsequent encounter context is critical for accurate coding.

Treatment Options

Treatment focuses on stabilizing the patient, managing symptoms, and addressing underlying psychiatric needs. Interventions may include airway support, antidotes (if available), and psychiatric evaluation. Ongoing care often involves mental health support and medication management.

Prognosis and Follow-Up

Prognosis depends on the severity of poisoning and response to treatment. Follow-up care typically includes psychiatric assessment, therapy, and monitoring for recurrence. Long-term management may involve medication adjustments or support services.

Complications

• Severe neurological damage (e.g., seizures, coma).
• Respiratory failure requiring mechanical ventilation.
• Cardiovascular instability or organ dysfunction.
• Psychiatric complications (e.g., persistent depression, suicidal ideation).
• Long-term cognitive or physical impairments.

Lifestyle & Prevention

• Secure storage of medications to prevent access.
• Regular psychiatric follow-up and therapy.
• Education on medication safety and self-harm risks.
• Support from family, friends, or mental health professionals.
• Avoidance of triggers or stressors that may contribute to self-harm.

When to Seek Professional Help

Seek immediate medical attention if symptoms of poisoning occur, such as drowsiness, confusion, seizures, or respiratory distress. Contact a mental health professional if experiencing suicidal thoughts or self-harm urges.

Tips for Medical Coders

Use this code for intentional self-harm poisoning by succinimides or oxazolidinediones during a subsequent encounter. Document the self-harm intent, clinical findings, and encounter type clearly. Ensure the code aligns with the patient’s history and ongoing care context.